AI-Powered Diagnostic Tool for Renal Oncocytic Neoplasms Shows Promising Results

Strategic Insights -

Research conducted by a team of experts from the Indiana University School of Medicine has led to the development of an artificial intelligence-powered diagnostic tool for distinguishing between renal oncocytic tumors and a subset of tumors with overlapping characteristics. The study, published in the Archives of Pathology & Laboratory Medicine, aimed to create an automatic computational classifier for stratifying whole slide images of biopsy and resection specimens.

Key Takeaways:

  • The research involved the collection of 269 whole slide images from 125 cases across 6 institutions.
  • A weakly supervised attention-based multiple-instance-learning deep learning (DL) model was trained and evaluated through 5-fold cross validation with case-level stratification.
  • The developed model showed generalizable performance, with a 5-fold average testing accuracy of 84% (AUC = 0.78) and a closely aligning accuracy of 83% (AUC = 0.92) on the independent holdout data set.
  • The proposed AI approach contributed toward a comprehensive solution for addressing commonly encountered renal oncocytic neoplasms, encompassing well-established entities like renal oncocytoma and low-grade oncocytic tumor.
  • The authors aim to extend the proposed model to a 3-class model including chromophobe renal cell carcinoma in future research.

Statistics:

  • 269 whole slide images were collected from 125 cases across 6 institutions.
  • The 5-fold average testing accuracy of the developed model was 84% (AUC = 0.78).
  • The accuracy of the model on the independent holdout data set was 83% (AUC = 0.92).
  • The study was conducted over an unspecified period, with the research being published in the Archives of Pathology & Laboratory Medicine in 2025.

Sources:

  • "Advancing From a 2-class Model of Renal Oncocytoma and Low-grade Oncocytic Tumor To a 3-class Model Including Chromophobe Renal Cell Carcinoma." Archives of Pathology & Laboratory Medicine, 2025;149(10):922-929.
  • NewsRx. Findings from Indiana University School of Medicine Broaden Understanding of Carcinomas (Advancing From a 2-class Model of Renal Oncocytoma and Low-grade Oncocytic Tumor To a 3-class Model Including Chromophobe Renal Cell Carcinoma). Health & Medicine Week. October 31, 2025; p 145.